DEA's Mysterious Memo on Dr. Konen: Details? What Details?
Published Date: 8/20/2025
Notice
Summary
Dr. Andrew Konen from Dallas lost his DEA license because he wrote lots of prescriptions for strong drugs in ways that weren’t legal or safe. He didn’t show up to defend himself, so the government decided to revoke his registration and deny any future applications. This means he can’t legally prescribe controlled substances anymore, starting now.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Dr. Konen
The Drug Enforcement Administration revoked Andrew Konen, M.D.'s DEA certificate of registration (BK4924139) and denied all pending registration applications he had in Texas. The OSC that led to this action was issued August 12, 2024, and the Decision and Order was published August 20, 2025.
Default Rule: Missed Deadlines Can Forfeit Hearing
Under DEA rules (21 CFR 1301.37(d) and 1301.43), a person served with an Order to Show Cause has 30 days to request a hearing and answer the allegations; an unexcused default can be deemed a waiver of the right to a hearing and an admission of the OSC's factual allegations. The final rule implementing this framework became effective December 14, 2022, and was applied in this case after missed prehearing deadlines in September–October 2024.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-17592, Thomas Earley, D.D.S.; Decision and Order
Dr. Thomas Earley from Ohio lost his DEA registration because he no longer has permission to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA canceled his registration by default. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately.
2026-17594, Atlantic Treatment Center, LLC; Decision and Order
The DEA has officially shut down Atlantic Treatment Center in Florida because it lost its state license and federal certification to treat substance use disorders. This means the center can no longer operate legally, protecting public health and safety. The center’s DEA registration expired on June 30, 2026, and this decision finalizes the revocation, making it clear no more services can be offered.
2026-17589, Leila Kump, M.D.; Decision and Order
2026-17531, Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
The Drug Enforcement Administration (DEA) issues this temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4- yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968); 5,6-dichloro-1-(1-(4- chlorobenzyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro desmethylchlorphine or SR-17018); 3-(3- (1-(1-(4-chlorophenyl)ethyl)piperidin-4-yl)-2-oxo-2,3-dihydro-1H- benzo[d]imidazol-1-yl)propanenitrile (commonly known as N-propionitrile chlorphine or cychlorphine); and 8-(1-(4-chlorophenyl)ethyl)-1-phenyl- 1,3,8-triazaspiro[4.5]decan-4-one (commonly known as spirochlorphine or R-6890), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible, to schedule I under the Controlled Substances Act. DEA bases this action on a finding that placing 5,6-dichloro brorphine, 5,6-dichloro desmethylchlorphine, N- propionitrile chlorphine, and spirochlorphine in schedule I is necessary to avoid an imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these substances.
Previous / Next Documents
Previous: 2025-15865, Agency Information Collection Activity: Application for Disability Compensation and Related Compensation Benefits
The VA wants your thoughts on updating the form veterans use to apply for disability benefits. This is a chance to help make the process smoother and easier for those who served. You’ve got 60 days to share your feedback—no money changes yet, just a heads-up to improve the paperwork!
Next: 2025-15867, Kenneth Pherson, D.O.; Decision and Order
Kenneth Pherson, D.O., lost his DEA registration because he no longer has permission to handle controlled substances in Florida. He didn’t ask for a hearing after being notified, so the DEA moved forward and officially revoked his registration. This means Dr. Pherson can’t legally prescribe or manage controlled drugs anymore, effective immediately.